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Abstract
Background: Hemotropic mycoplasmas (hemoplasmas), the agents of infectious anemia, have been reported in
dogs and cats. Little data are available on hemoplasma infections in Italy. The aim of this study was to evaluate the
species of hemoplasmas and their prevalence in dogs and cats of northern Italy.
Methods: Blood samples were obtained from 117 candidate blood donor dogs, 278 free-roaming dogs and 227
free-roaming cats in 2014 and 2015. Samples were first screened for hemoplasmas with a SYBR green real time PCR.
The positive samples were confirmed by a second SYBR green real time PCR and sequencing. Co-infections were
detected using species-specific SYBR green real time PCR.
Results: The overall prevalence in dogs was 4.5% (18/395). Among the donors only one dog was positive for
Mycoplasma haemocanis (0.8%). The overall prevalence of infection in free-roaming dogs was 6.1% (17/278),
which was significantly higher than in candidate donors (P < 0.05). Both M. haemocanis (13/278; 4.7%) and “Candidatus
M. haematoparvum” (4/278; 1.4%) were identified. In dogs, no significant association was found between hemoplasma
infection and gender, age or origin. The overall prevalence in cats was 13.2% (30/227). All three feline hemoplasma
species were detected, i.e. “Candidatus Mycoplasma haemominutum” (28; 12.3%), “Candidatus Mycoplasma turicensis”
(11; 4.8%) and Mycoplasma haemofelis (9; 4.0%). Half of the infected cats were co-infected (15; 6.6%) with different
species of hemoplasmas. Risk factor analysis confirmed that older age, male gender and FIV positivity are predisposing
factors for hemoplasma infection in cats.
Conclusion: This study found that candidate blood donor dogs in northern Italy show a negligible risk for
hemoplasma infection, confirming the appropriateness of the candidate selection criteria and the low prevalence in
the study area. Accordingly, testing for hemoplasma should be considered optional for canine blood donor screening.
Hemoplasma infection was instead common in free-roaming cats, and is expected to be non-negligible in owned cats
with outdoor access. Feline candidates for blood donation will therefore need to be carefully selected.
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Background
Hemotropic mycoplasmas (hemoplasmas) are small
epicellular parasites that adhere to the erythrocytes of
infected animals. They are the causative agents of infec-
tious anemia in several mammalian species, including
dogs and cats. Transmission can occur via infected
blood, as through blood transfusion, and aggressive in-
teractions. Blood-sucking arthropods like fleas and ticks
have also been suggested to be possible vectors, but
their ability to transmit the infection has not yet been
experimentally confirmed. A role for mites in mechan-
ical transmission of infection has been proposed for
dogs [1]. The clinical picture can range from asymp-
tomatic infection to acute hemolytic anemia and can
induce anorexia, lethargy, dehydration, weight loss and
sudden death [1].
Different species of hemoplasma have been described
affecting wild and domestic animals worldwide. Two differ-
ent species are recognized in dogs: Mycoplasma haemoca-
nis (Mhc) and “Candidatus Mycoplasma haematoparvum”
(“CMhp”) [2, 3]. Three hemoplasma species are recognized
in cats: Mycoplasma haemofelis (Mhf) [4], “Candidatus
Mycoplasma haemominutum” (“CMhm”) [5] and “Candi-
datus Mycoplasma turicensis” (“CMt”) [6, 7].
Recently, “CMhm” and “CMt” were detected in dogs
in Japan [8] and Chile [9], respectively and “Candidatus
Mycoplasma haematoparvum-like” was found in cats in
Portugal [10], California [11] and Chile [12].
Little data are available on hemoplasma infections in
dogs and cats in Italy. The prevalence of infection in
dogs with different lifestyles (kennel and owned dogs),
sampled in three cities throughout the country, was
7.5% in Northern Italy, 9.5% in Central Italy and 11.5%
in Sicily [13]. In northern Italy, the overall prevalence of
hemoplasma infection was 18.9% in owned cats sampled
at a veterinary clinic [14] and 33.1% in cats living in col-
onies [15]. In southern Italy, owned cats with a predomin-
antly outdoor lifestyle showed a prevalence of 26.2% [16].
The aim of this study was to evaluate the species of
hemoplasmas and their prevalence in owned dogs and
free-roaming dogs and cats of northern Italy. These data
are also required to better guide the molecular screening
of canine candidate blood donors.
Methods
Recruitment and data collection
Overall 622 blood samples were collected in EDTA,
from 117 owned candidate blood donor dogs (CBDs),
278 free-roaming dogs (FRDs) and 227 free-roaming cats
(FRCs) in 2014 and 2015.
The CBDs fulfilled the following inclusion criteria:
age 2–8 years, body weight ≥ 25 kg, clinically healthy,
regularly vaccinated and protected against endo- and
ectoparasites. The CBDs came from several municipalities
of northern and north-eastern Italian provinces (Padua,
Treviso, Verona, Venice, Milan and Bologna).
The FRDs came from two shelters in the provinces of
Treviso and Padua. At entry into the shelters they were
sampled and clinically evaluated by the local veterinary
health units, in the framework of a zoonotic agent con-
trol and staff protection program. The FRDs included in
this study had no apparent clinical signs.
The FRCs had been rescued and were based at a single
cat shelter (Novara Province), where they had outdoor
access in a confined environment. They underwent clin-
ical evaluation and blood sampling during sterilization.
All blood samples were then submitted to the IDEXX
Laboratories (Novara, Italy) for a complete cell blood
count and evaluation of the cats’ FIV/FeLV status (feline
immunodeficiency virus/feline leukemia virus) by the
SNAP® FIV/FeLV Combo test (IDEXX Laboratories,
Westbrook, ME-USA). The sensitivity and specificity of
the Snap test were reported to be: FIV (93.5–100%) and
FeLV (98.6–98.2%). Anemia was defined as a deficiency
of red blood cells (<5 M/μl in cats and 5.3 M/μl in dogs)
or of hemoglobin in the blood (< 9 g/dl in cats and
13 g/dl in dogs). No other information was available. An
aliquot of each sample was frozen at -20 °C and stored
until DNA extraction.
Based on clinical evaluation and blood test results, 170
cats were classified as healthy, the remaining were anemic
and/or positive to FIV/FeLV.
Molecular analysis
To detect and characterize hemoplasma infections in
cats and dogs we used the following approach: (i) a first
screening was performed using a sensitive SYBR green
real time PCR (rPCR) (16S rRNA gene) to select positive
samples of known and unknown species; (ii) the positive
samples underwent a second SYBR green rPCR (16S
rRNA gene) to amplify a longer PCR product suitable
for sequencing and species identification; (iii) a SYBR
green rPCR targeting the RNaseP gene was used to dis-
tinguish between Mhf and Mhc species; and (iv) species-
specific rPCRs (16S rRNA gene) were applied to positive
samples to detect co-infections.
Nucleic acid extraction and internal control
DNA was extracted from 100 μl of EDTA-blood samples
using a DNeasy Blood & Tissue kit (Qiagen, Valencia,
CA, USA), according to the manufacturer’s instructions.
The DNA was eluted in 200 μl elution buffer and stored
at -20 °C until use. A negative control (PBS) was used in
parallel with the extraction of each set of samples. Before
screening the hemoplasmas, all the samples were ampli-
fied using a traditional PCR targeting the 18S rRNA in-
ternal control, to ensure the effectiveness of the nucleic
acid extraction [17].
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Screening
Samples were screened using a SYBR green rPCR, per-
formed with the primers Mycf (5′-AGC AAT RCC ATG
TGA ACG ATG AA-3′) and MycR1 (5′-TGG CAC
ATA GTT TGC TGT CAC TT-3′), as previously de-
scribed [18]. The reactions were carried out in a total
volume of 20 μl, containing 10 μl of QuantiFast SYBR
Green PCR Master mix 2× (Qiagen GmbH, Germany),
0.1 μM of sense and reverse primer and 3 μl of extracted
DNA. Amplifications were performed in a StepOnePlus™
instrument (Applied Biosystems, Foster City, CA). The
thermal profile consisted of 5 min at 95 °C, followed by
40 cycles at 95 °C for 15 s, 62 °C for 30 s and 60 °C for
30 s. Following amplification, dissociation was per-
formed by slowly raising the temperature of the ther-
mal chamber from 60 to 95 °C. Negative (sterile water)
and positive controls (DNA of Mhc) were included in
each run.
Hemoplasma species identification
Since the amplicon produced by the screening rPCR was
too short (127 bp) for good species identification [18],
all hemoplasma-positive samples were amplified using a
newly designed SYBR green rPCR based on conserved
regions of the 16S rRNA gene (MycE929f: 5′-ACG GGG
ACC TGA ACA AGT GGT G-3′ and MycE1182r: 5′-
AGG CAT AAG GGG CAT GAT GAC TTG-3′). This
PCR was designed to amplify a 259 bp PCR product, to
allow species identification following sequencing.
The reactions were carried out in a total volume of
20 μl, containing 10 μl of QuantiFast SYBR Green PCR
Master mix 2× (Qiagen GmbH, Germany), 0.1 μM of
sense and reverse primer (MycE929f - MycE1182r) and
3 μl of extracted DNA. Amplifications were performed
in a StepOnePlus™ instrument (Applied Biosystems, Foster
City, CA, USA). The thermal profile consisted of 5 min at
95 °C, followed by 40 cycles at 95 °C for 15 s, 60 °C for
30 s and 60 °C for 30 s. Following amplification, melting
curve analysis was performed by slowly raising the
temperature of the thermal chamber from 60 to 95 °C to
distinguish between hemoplasma amplicons (Tm range
76.2–77.3 °C) and non-specific amplification products.
Negative (sterile water) and positive controls (DNA of
Mhc) were included in each run.
The sensitivity of this rPCR was determined using syn-
thetic DNA of Mhc. After spectrophotometrically deter-
mining the concentration, the plasmid DNA copy numbers
were calculated with the formula: Y =X/(a × 660) × 6.022 ×
1023, where: Y =molecules/μl; X = g/μl dsDNA; a = plasmid
plus insert length in nucleotides; 660 is the average molecu-
lar weight per nucleotide of dsDNA. The detection limit,
evaluated using 10-fold serial dilutions of synthetic DNA,
tested in triplicate, was 101 DNA copies/rPCR. The inclu-
sivity of the assay was confirmed by analyzing canine and
feline hemoplasma reference strains of Mhc, “CMhp”, Mhf,
“CMhm” and “CMt”.
In addition, since the 16S rRNA gene sequence is
identical for Mhf and Mhc, the positive samples of these
two species were amplified, using the RNase P gene
primers RNasePFor1 and RNasePrev1, which more reli-
ably differentiate between the two species, and sequenced
[19]. The reactions were carried out in a total volume of
20 μl, containing 10 μl of QuantiFast SYBR Green PCR
Master mix 2× (Qiagen GmbH, Germany), 0.1 μM of
sense and reverse primer and 3 μl of extracted DNA. Am-
plifications were performed in a StepOnePlus™ instrument
(Applied Biosystems, Foster City, CA, USA). The thermal
profile consisted of 5 min at 95 °C, followed by 40 cy-
cles at 95 °C for 15 s, 58 °C for 30 s and 60 °C for 30 s.
Following amplification, dissociation was performed by
slowly raising the temperature of the thermal chamber
from 60 to 95 °C. Negative (sterile water) and positive
controls (DNA of Mhc and Mhf ) were included in
each run.
The PCR products obtained with 16S rRNA and the
RNase P gene were directly sequenced. Sequencing was
performed with 16S rRNA gene primers MycE929f and
MycE1182r and with RNase P gene primers RNasePFor1
and RNasePrev1, using the Big Dye Terminator v3.1 cycle
sequencing kit (Applied Biosystems, Foster City, CA, USA).
The products were purified using the PERFORMA DTR
Ultra 96-Well kit (Edge BioSystems, Gaithersburg, MD,
USA) and sequenced in a 16-capillary ABI PRISM 3130xl
Genetic Analyzer (Applied Biosystems, Foster City, CA,
USA). Sequence data were assembled and edited with
SeqScape software v2.5 (Applied Biosystems, Foster City,
CA, USA). The sequence data were compared with repre-
sentative sequences available in GenBank, using the Basic
Local Alignment Search Tool (BLAST) [20] to identify
hemoplasma species.
Co-infections
Finally, species-specific real time PCRs were applied
to positive samples to detect co-infections, using for-
ward primer “Mycoplasma species-F” coupled with
four reverse primers specific for Mhf/Mhc, CMhm,
CMhp and CMt (“Mycoplasma haemofelis-R”, “Candi-
datus Mycoplasma haemominutum-R”, “Candidatus
Mycoplasma haematoparvum-R”, “Candidatus Myco-
plasma turicensis-R”, respectively), applying a previ-
ously described method and conditions [11].
Statistical analysis
Differences in hemoplasma prevalence between animal
populations stratified by age, gender, lifestyle (FRDs vs
donors, in the case of dogs) and age, gender, anemic
status and FIV or FeLV test results (in the case of cats),
were first tested for statistical significance through
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univariate analysis, using the Chi-square test or Fisher’s
exact test, where appropriate.
The variables significantly associated with hemoplasma
infection in the univariate testing were analysed by
means of logistic regression models to evaluate potential
risk factors associated with hemoplasma prevalence [21].
In logistic regression, the hemoplasma infection repre-
sented the dependent variable and the animal’s features
represented the independent variables. The variable
“age” was coded as 0 for young (up to one year) and 1
for adults; “gender” was coded as 0 for female and 1 for
male; “FIV/FeLV” was coded as 0 for negative and 1 for
positive, and “anemia” was coded as 0 for non-anemic
and 1 for anemic cat. Collinearity among independent
variables was controlled using the Pearson correlation
coefficient. The significance was set at P < 0.05. The soft-
ware used was SPSS for Windows, version 13.0.
Results
The overall prevalence of hemoplasma infection in dogs
was 4.5% (18/395). Only one CBD was positive for Mhc
(1/117; 0.8%). The prevalence of hemoplasma infection
among FRDs was 6.1% (17/278) and both Mhc (13/278;
4.7%) and “CMhp” (4/278; 1.4%) were identified.
Neither co-infections nor hemoplasma species typical
of cats were detected in dogs. The prevalence of hemo-
plasmas was significantly higher in FRDs compared to
CBDs (χ2 = 7.423, df = 1, P = 0.0064). Among FRDs, no
differences were observed in the prevalence of hemo-
plasma infection by age group, gender and province of
origin (Table 1). The overall prevalence of infection in
cats was 13.2% (30/227). All three species affecting cats
were found, i.e. “CMhm” (28/227; 12.3%), “CMt” (11/
227; 4.8%), and Mhf (9/227; 4.0%). Half of the positive
cats were co-infected (15/227; 6.6%) with different species
of hemoplasmas, i.e. 12 showed double co-infections
(eight “CMhm”/Mhf and four “CMhm”/”CMt”) and three
had triple co-infections. Hemoplasma species typical of
dogs were not found in cats.
Hemoplasma-infected cats were more likely to be
males (χ2 = 12.404, df = 1, P < 0.0001) and to be older
than 1 year of age (χ2 = 24.944, df = 1, P < 0.0001) (Table 2).
The prevalence of hemoplasmas was significantly higher
in FIV-positive cats (65.2% vs 7.4%) (χ2 = 54.063, df = 1,
P < 0.0001), but not in FeLV-positive felines, and was
also significantly higher in anemic cats (25.8 vs 11.2%;
χ2 = 4.962, df = 1, P = 0.026) (Table 2). Regarding the
prevalence of hemoplasmas in anemic cats stratified by
Table 1 Prevalence of hemoplasmas in 278 free-roaming dogs of Northern Italy. No significant differences were found




Gender Female 78 5 (6.4) 2 (2.6) 3 (3.8)
Male 196 11 (5.6) 10 (5.1) 1 (0.5)
Agea young (≤ 1 year) 56 1 (1.8) 1 (1.8) 0 (0.0)
adult (> 1 year) 99 2 (2.0) 1 (1.0) 1 (1.0)
Province Padua 112 4 (3.6) 2 (1.8) 2 (1.8)
Treviso 166 13 (7.8) 11 (6.6) 2 (1.2)
aEstimated age available only for dogs from the Padua shelter
Abbreviations: Mhc Mycoplasma haemocanis, “CMhp” “Candidatus Mycoplasma haematoparvum”
Table 2 Prevalence of hemoplasmas in 227 cats from northern Italy (Novara Province). Significant differences are marked with equal
letters (uppercase, P < 0.01; lowercase, P < 0.05)
Variables No. of dogs Hemoplasma (%) “CMhm” (%) Mhf (%) “CMt” (%)
Gender Female 119 3 (2.5)A 3 (2.5)B 0 (0.0)C 0 (0.0)D
Male 108 27 (25.0)A 25 (23.1)B 9 (8.3)C 11 (10.2) D
Age Young (≤ 1 year) 120 7 (5.8)E 7 (5.8)F 3 (2.5) 2 (1.7)g
Adult (> 1 year) 101 22 (21.8)E 20 (19.8)F 6 (5.9) 8 (7.9)g
Anemia Yes 31 8 (25.8)h 7 (22.6) 4 (12.9)i 3 (9.7)
No 196 22 (11.2)h 21 (10.7) 5 (2.5)i 8 (4.1)
FIV Positive 23 15 (65.2)L 13 (56.5)M 7 (30.4)N 7 (30.4)O
Negative 204 15 (7.4)L 15 (7.4)M 2 (1.0)N 4 (2.0)O
FeLV Positive 13 2 (15.4) 2 (15.4) 1 (7.7) 0 (0.0)
Negative 214 28 (13.1) 26 (12.1) 7 (3.3) 11 (5.1)
Abbreviations: “CMhm””Candidatus Mycoplasma haemominutum”, Mhf Mycoplasma haemofelis, “CMt” “Candidatus Mycoplasma turicensis”, no number
Ravagnan et al. Parasites & Vectors  (2017) 10:132 Page 4 of 7
Mycoplasma species, only anemic cats infected by the
Mhf species were significantly more positive than
healthy cats (12.9 vs 2.5%; χ2 = 5.060, df = 1, P = 0.0245).
Multivariate analysis confirmed male gender (OR =
13.168), older age (OR = 3.666) and FIV positivity (OR
= 13.859) to be risk factors (Table 3).
Discussion
This study highlights that most of the known species of
hemoplasmas of dogs and cats are present in northern
Italy. The overall prevalence of hemoplasmas in our
dogs (4.5%) and cats (13.2%) is comparable with several
previous studies. One study on canine hemoplasmas in
600 dogs from northern, central and southern Italy
showed prevalences of 7.5, 9.5 and 11.5%, respectively
[13]. Studies performed in owned cats from veterinary
clinics reported prevalence rates of 18.9% (n = 307) in
northern Italy [14] and 26.2% (n = 42) in southern Italy
[16]. A much higher prevalence of 31.3% was found in
206 cats from colonies of Milan, in north-western Italy
[15]. This rate was also higher than the majority of other
studies performed in Europe and the authors attributed
the difference to the type of population sampled (stray
colony cats), which presented several risk factors simul-
taneously, i.e. a high percentage of unhealthy cats (includ-
ing anemia, FIV positivity and other clinical/pathological
abnormalities), a higher probability of aggressive interac-
tions in colonies, and abundant flea populations.
Other studies performed in Europe revealed a marked
difference in prevalence among countries. The preva-
lence ranged from 1.2 to 40% in dogs (Table 4) and
from 9 to 43.3% in cats (Table 5). This is likely due to
several factors, i.e. the sampled populations, geograph-
ical variations and the different diagnostic techniques
used, from microscopic examination to molecular
detection.
Our study showed that free-roaming dogs were more
frequently infected than candidate blood donors, in
which the prevalence of hemoplasmas was negligible.
This finding is most likely explained by the regular use
of compounds against arthropod vectors and greater
owner care. Living in kennels was in fact found to be a
risk factor in dogs from Mediterranean countries [13].
No association between hemoplasma prevalence and
other potential risk factors was found in the dogs stud-
ied by us (Table 1), in accordance with a recent study
[22] that in addition found no association with breed,
clinical status, tick presence, ectoparasite prophylaxis
and anemia. In other studies, young and male dogs
seemed to be more susceptible to canine hemoplasma
infections [13, 23]. Other risk factors could include
cross-breeding and mange infection [11], presence of
vectors, older age, dog bite wounds, neoplastic diseases,
dogs of rural vs urban localities [9, 24]. This heterogen-
eity of results in respect to possible risk factors for
hemoplasma infection in dogs may reflect the presence
of confounding factors or weak associations.
Our study confirmed that “CMhm” is the prevalent
species in cats and that co-infection is frequent. The
different feline hemoplasma species have different patho-
genic potential. Mhf was found to be more pathogenic
than “CMhm” [25, 26], while “CMt” could induce mild to
moderate anemia [6, 27, 28]. In our study “CMhm” was
more prevalent in cats with anemia compared to other
species, but only Mhf was found to be significantly more
represented in anemic compared to healthy cats, confirm-
ing the above studies. Anemia did not arise as a risk factor
for hemoplasma infection, but this is consistent with
the fact that anemia is a consequence of the infection
(at least in the case of Mhf and “CMt”) rather than a
predisposing factor.
In our cats, male gender, adult age and FIV positivity
were found to be risk factors for hemoplasma infection,
confirming several other studies [1, 6, 12, 13, 22, 27–29].
The authors concur in explaining the reasons for these
associations, i.e. (i) male cats, especially if they are not
Table 3 Results of the multivariate analysis for potential risk factors in cats
Independent variables B SE Wald df P Exp(B) (Odds ratio) 95% CI for Exp(B)
Age 1.299 0.561 5.371 1 0.020 3.666 1.222–10.996
Gender 2.578 0.698 13.637 1 0.000 13.168 3.352–51.725
FIV 2.629 0.644 16.690 1 0.000 13.859 3.926–48.921
FELV 1.521 1.169 1.692 1 0.193 4.577 0.463–45.292
Anemia 0.081 0.717 0.013 1 0.910 1.085 0.266–4.422
Constant -5.018 0.802 39.139 1 0.000 0.007
Table 4 Percentage of animals PCR-positive for canine










Switzerland 1.2 0.9 0.3 0 [30]
Spain 2.5–14.3 0.5–14.3 0.6–2 0–0.6 [13, 31]
Portugal 40.0 40.0 0 0 [13]
France 15.4 5.8 12.2 2.6 [32]
Italy 9.5 4.5 5.8 0.8 [13]
Abbreviations: Mhc Mycoplasma haemocanis, “CMhp” “Candidatus
Mycoplasma haematoparvum”
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neutered, have more aggressive interactions which may
enhance transmission via infected blood; (ii) adult animals
have been exposed to blood-sucking arthropods for longer
and also have more aggressive interactions; and (iii) FIV
positivity is associated with an immune-suppression sta-
tus. However, FIV positivity and hemoplasma infection
may be related simply because they share the same route
of transmission through bite wounds.
The molecular protocol used in our study was suitable
for the identification of all five species of hemoplasmas
in both dogs and cats and can be applied to both the
diagnosis and screening of blood donors.
Conclusions
This study found that canine candidate blood donors in
northern Italy showed a negligible risk for hemoplasma
infections, confirming the appropriateness of candidate
selection criteria and the low prevalence in the study area.
Accordingly, testing for hemoplasma should be consid-
ered optional for the screening of canine blood donors in
this epidemiological setting. By contrast, our results con-
firmed that hemoplasma infection is a common finding in
cattery cats of northern Italy. Cats will therefore need to
be carefully selected as candidate blood donors, since
owned cats frequently have outdoor access and may show
risky behavior.
Abbreviations
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